Search Results - "FUESSEL, SUSANNE"

Refine Results
  1. 1

    Prognostic potential of standard laboratory parameters in patients with metastatic renal cell cancer receiving first-line immunotherapy by Buerk, Bjoern Thorben, Kusiek, Cathrin, Schüttke, Vayda, Sondermann, Marcus, Yakac, Abdulbaki, Abbate, Elena, Fuessel, Susanne, Thomas, Christian, Erdmann, Kati

    Published in Scientific reports (25-10-2024)
    “…Through their involvement in cancer metabolism, alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), γ-glutamyltransferase (GGT) and lactate…”
    Get full text
    Journal Article
  2. 2

    Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer by Stasik, Sebastian, Salomo, Karsten, Heberling, Ulrike, Froehner, Michael, Sommer, Ulrich, Baretton, Gustavo B., Ehninger, Gerhard, Wirth, Manfred P., Thiede, Christian, Fuessel, Susanne

    Published in Clinical biochemistry (01-02-2019)
    “…Cell-free DNA (cfDNA) is proposed to be a valuable source of biomarkers in liquid biopsies for various diseases as it is supposed to partially originate from…”
    Get full text
    Journal Article
  3. 3

    Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines by Linke, Dinah, Donix, Lukas, Peitzsch, Claudia, Erb, Holger H H, Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati

    “…Docetaxel (DTX) is a mainstay in the treatment of metastatic prostate cancer. Failure of DTX therapy is often associated with multidrug resistance caused by…”
    Get full text
    Journal Article
  4. 4

    Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines by Donix, Lukas, Erb, Holger H. H., Peitzsch, Claudia, Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati

    “…Purpose Platinum chemotherapy can be considered to treat metastatic castration-resistant prostate cancer (mCRPC) with features of neuroendocrine…”
    Get full text
    Journal Article
  5. 5

    Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer by Erb, Holger H H, Bodenbender, Julia, Handle, Florian, Diehl, Tamara, Donix, Lukas, Tsaur, Igor, Gleave, Martin, Haferkamp, Axel, Huber, Johannes, Fuessel, Susanne, Juengel, Eva, Culig, Zoran, Thomas, Christian

    Published in PloS one (13-08-2020)
    “…Despite enzalutamide's efficacy in delaying the progression of metastatic castration-resistant prostate cancer (CRPC), resistance to this anti-androgen…”
    Get full text
    Journal Article
  6. 6

    Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer by Erdmann, Kati, Salomo, Karsten, Klimova, Anna, Heberling, Ulrike, Lohse-Fischer, Andrea, Fuehrer, Romy, Thomas, Christian, Roeder, Ingo, Froehner, Michael, Wirth, Manfred P, Fuessel, Susanne

    “…Currently, voided urine cytology (VUC) serves as the gold standard for the detection of bladder cancer (BCa) in urine. Despite its high specificity, VUC has…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma by Dornbusch, Juana, Zacharis, Aristeidis, Meinhardt, Matthias, Erdmann, Kati, Wolff, Ingmar, Froehner, Michael, Wirth, Manfred P, Zastrow, Stefan, Fuessel, Susanne

    Published in PloS one (27-09-2013)
    “…Patients with metastatic clear cell renal cell carcinoma (ccRCC) are frequently treated with tyrosine kinase inhibitors (TKI) such as sunitinib. It inhibits…”
    Get full text
    Journal Article
  10. 10

    Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer by Schulz, Alexander, Gorodetska, Ielizaveta, Behrendt, Rayk, Fuessel, Susanne, Erdmann, Kati, Foerster, Sarah, Datta, Kaustubh, Mayr, Thomas, Dubrovska, Anna, Muders, Michael H

    Published in Frontiers in oncology (21-01-2020)
    “…Neuropilin-2 (NRP2) is a prognostic indicator for reduced survival in bladder cancer (BCa) patients. Together with its major ligand, vascular endothelial…”
    Get full text
    Journal Article
  11. 11

    WNT5A Has Anti‐Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo by Thiele, Stefanie, Göbel, Andy, Rachner, Tilman D, Fuessel, Susanne, Froehner, Michael, Muders, Michael H, Baretton, Gustavo B, Bernhardt, Ricardo, Jakob, Franz, Glüer, Claus C, Bornhäuser, Martin, Rauner, Martina, Hofbauer, Lorenz C

    Published in Journal of bone and mineral research (01-03-2015)
    “…ABSTRACT Prostate cancer is the most frequent malignancy in men, and a major cause of prostate cancer–related death is attributable to bone metastases. WNT5A…”
    Get full text
    Journal Article
  12. 12

    Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation by Erdmann, Kati, Ringel, Jessica, Hampel, Silke, Wirth, Manfred P, Fuessel, Susanne

    Published in Beilstein journal of nanotechnology (23-06-2017)
    “…We have previously shown that carbon nanofibers (CNFs) and carbon nanotubes (CNTs) can sensitize prostate cancer (PCa) cells to platinum-based…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Role of WNT5A receptors FZD5 and RYK in prostate cancer cells by Thiele, Stefanie, Zimmer, Ariane, Göbel, Andy, Rachner, Tilman D, Rother, Sandra, Fuessel, Susanne, Froehner, Michael, Wirth, Manfred P, Muders, Michael H, Baretton, Gustavo B, Jakob, Franz, Rauner, Martina, Hofbauer, Lorenz C

    Published in Oncotarget (05-06-2018)
    “…Prostate cancer is the most common malignancy in men and has a high propensity to metastasize to bone. WNT5A has recently been implicated in the progression of…”
    Get full text
    Journal Article
  15. 15

    Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer by Borkowetz, Angelika, Lohse-Fischer, Andrea, Scholze, Jana, Lotzkat, Ulrike, Thomas, Christian, Wirth, Manfred P, Fuessel, Susanne, Erdmann, Kati

    Published in Diagnostics (Basel) (09-08-2020)
    “…Currently used tumor markers for early diagnosis of prostate cancer (PCa) are often lacking sufficient specificity and sensitivity. Therefore, the diagnostic…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma by Toma, Marieta I, Erdmann, Kati, Diezel, Michael, Meinhardt, Matthias, Zastrow, Stefan, Fuessel, Susanne, Wirth, Manfred P, Baretton, Gustavo B

    Published in PloS one (15-07-2014)
    “…The EPH receptor tyrosine kinases and their cell-bound ligands, the ephrins, have been shown to be associated with cancer development and progression. In this…”
    Get full text
    Journal Article
  18. 18

    Chemosensitizing effects of carbon-based nanomaterials in cancer cells: enhanced apoptosis and inhibition of proliferation as underlying mechanisms by Erdmann, Kati, Ringel, Jessica, Hampel, Silke, Rieger, Christiane, Huebner, Doreen, Wirth, Manfred P, Fuessel, Susanne

    Published in Nanotechnology (10-10-2014)
    “…Recent studies have shown that carbon nanomaterials such as carbon nanofibres (CNFs) and multi-walled carbon nanotubes (CNTs) can exert antitumor activities…”
    Get more information
    Journal Article
  19. 19

    Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis by BLUEMKE, Karen, BILKENROTH, Udo, MEYE, Axel, FUESSEL, Susanne, LAUTENSCHLAEGER, Christine, GOEBEL, Steffen, MELCHIOR, Andres, HEYNEMANN, Hans, FORNARA, Paolo, TAUBERT, Helge

    “…Purpose: The aim of this study was to evaluate the clinical relevance of the presence of disseminated tumor cells in peripheral blood (so-called circulating…”
    Get full text
    Journal Article
  20. 20

    Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates by Thiele, Sylvia, Rauner, Martina, Goettsch, Claudia, Rachner, Tilman D., Benad, Peggy, Fuessel, Susanne, Erdmann, Kati, Hamann, Christine, Baretton, Gustavo B., Wirth, Manfred P., Jakob, Franz, Hofbauer, Lorenz C.

    Published in Journal of cellular biochemistry (01-06-2011)
    “…Skeletal metastases represent a frequent complication in patients with advanced prostate cancer (PCa) and often require bisphosphonate treatment to limit…”
    Get full text
    Journal Article